Found 5 matching trials
A Phase 1b/2 Safety and Tolerability Study of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies
PHASE1The main purpose of this study is to determine the best dose of MEDI6469 th...
Anti-OX40 Antibody (MEDI6469) in Patients With Metastatic Colorectal Cancer
PHASE1This study will test the ability of an immune modulator, anti-OX40 (MEDI646...
Location
Portland Providence Medical Center
Stereotactic Body Radiation and Monoclonal Antibody to OX40 (MEDI6469) in Breast Cancer Patients With Metastatic Lesions
PHASE1This study will test the investigational antibody, MEDI6469 (anti-OX40), in...
Location
Portland Providence Medical Center
Anti-OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate Cancer
PHASE1This clinical trial will examine a novel combination of anti-OX40 to induce...
Location
Providence Portland Medical Center
Anti-OX40 Antibody in Head and Neck Cancer Patients
PHASE1The purpose of this study is to test the safety of the anti-OX40 antibody, ...
Location
Portland Providence Medical Center